Levels of progranulin can be measured in patient plasma and were shown to be decreased in both GRN mutation carriers and pre-symptomatic GRN carriers compared to controls without significant differences between the three major FTD phenotypes represented by FTD, PPA, and CBS [154]. Here, CBS is linked to frontotemporal dementia.